Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/02/2008US7459482 Agent for treatment of cisplatin-resistant cancer
12/02/2008US7459481 Adust fatty acid oxidation; stimulant of carnitine plamitoyl treansferrase
12/02/2008US7459480 Benzodioxepine derivatives
12/02/2008US7459479 Benzylated PDE4 inhibitors
12/02/2008US7459478 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
12/02/2008US7459476 beta-secretase enzyme inhibitors; inhibiting deposition of A beta peptide; P-glycoprotein inhibitor; Down's syndrome, mild cognitive impairment; cerebral amyloid angiopathy, degenerative dementias; imidazole deivatives
12/02/2008US7459475 less side effects; higher potency; chronic and neuropathic pain, epilepsy, manic depression, bipolar disorder, diabetic neuropathy; 3-[3-(2-Trifluoromethoxyphenyl)-phenyl]-1,2,4-triazole
12/02/2008US7459474 1,2,4 triazole nonsteroidal derivatives; diseases associated with nuclear factor kappa beta induced transcription
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459472 Aryl and heteroaryl compounds, compositions, and methods of use
12/02/2008US7459471 Inclusion compound comprising cucurbituril derivatives as host molecule and pharmaceutical composition comprising the same
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459469 N-methyl-5-(5-isopropoxy-3-pyridinyl)-4-penten-2-amine p-hydroxybenzoate; compounds can activate nicotinic receptor and can modulate neurotransmitter secretion; neuroprotective agents; side effects reduction; pains; easy to remove impurities; heck coupling reaction; CNS disorders; inflammatory disorders
12/02/2008US7459468 3-{4-Hydroxymethyl-5[(2'-sulfamoyl-biphenyl-4-ylamino-methyl]-pyridin-3-yloxymethyl}-benzamidine; protease inhibitors of blood; block platelet aggregation; cardiovascular diseases like angioplasty, hypertrophy, congestive heart failure, arrhythmia, ischemia reperfusion injury; coating on a medical device
12/02/2008US7459467 selective and complete reduction of pyridine ring in a biaryl system comprising proportional-variant -substituted or non-substituted benzene ring; Attention Deficit Hyperactive Disorder (ADHD) and central nervous system stimulant
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459465 Isoquinoline compound and pharmaceutical use thereof
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008US7459461 Antiinflammatory agents; antihistamines; respiratory system disorders
12/02/2008US7459460 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
12/02/2008US7459457 Polycyclic pyridines as potassium ion channel modulators
12/02/2008US7459456 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459451 Pyrazolopyridine derivatives
12/02/2008US7459450 metabolic and eating disorders, symptoms of hepatitis C, pain, sexual dysfunction, congestive heart failure, cerebral hemorrhage, anxiety, depression, epileptic seizures, sleep disorders, migraine and allergic rhinitis.
12/02/2008US7459449 Olanzapine malonate, olanzapine glycolate, and olanzapine benzoate; antipsychotic agents; water soluble; can form tablets by direct compression; may be mixed with dibasic calcium phosphate and/or hydroxypropyl cellulose
12/02/2008US7459448 Lactam compounds useful as protein kinase inhibitors
12/02/2008US7459447 Method for treating hyperlipidemia
12/02/2008US7459446 Utilizing fructosamine oxidase enzyme inhibitors; minimizing macrovascular and microvascular damage
12/02/2008US7459445 Estrogenic compounds and topical pharmaceutical formulations of the same
12/02/2008US7459444 Inhibitors of chymase
12/02/2008US7459443 Synthesis of biologically active compounds in cells
12/02/2008US7459442 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
12/02/2008US7459432 adminsteration of Peptide YY or an agonist to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism
12/02/2008US7459431 Recombinant gelatin-like proteins for use as plasma expanders
12/02/2008US7459430 Calcium channel modulator; delayed or sustained release
12/02/2008US7459428 Treating Type II diabetes comprising coadministering metformin and an inhibitor of dipeptidylpeptidase IV, especially a peptidomimetic containing a pyrrolidine ring in an amount insufficient to suppress the immune system
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008US7459159 Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia
12/02/2008US7459154 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
12/02/2008US7459151 Phosphate-binding polymers for oral administration
12/02/2008US7459150 Heat activated durable conditioning compositions comprising an aminated C5 to C7 saccharide unit and methods for using same
12/02/2008US7459142 High viscosity embolizing compositions comprising prepolymers
12/02/2008CA2610819A1 Particles in a capsule
12/02/2008CA2516108C Polymorphs of donepezil hydrochloride and process for production
12/02/2008CA2515946C Use of palonosetron treating post-operative nausea and vomiting
12/02/2008CA2492417C Formulation for menopausal women
12/02/2008CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2460005C Enhancement of learning and memory and treatment of amnesia with the use of fused pyrazoles
12/02/2008CA2447354C Method of forming an aerosol for inhalation delivery
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2396111C Substances for use in treating psoriasis
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2381203C Formulations for treating or preventing mucositis
12/02/2008CA2377668C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
12/02/2008CA2372912C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
12/02/2008CA2372040C Imidazodiazepine derivative
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2359646C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
12/02/2008CA2352552C Treatment of erectile dysfunction
12/02/2008CA2346631C Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2340224C Nimesulide containing topical pharmaceutical compositions
12/02/2008CA2335485C Oregano for the treatment of internal parasites and protozoa
12/02/2008CA2335179C Tablet and process for making the same
12/02/2008CA2334022C Contaminant reduced marine oil
12/02/2008CA2333038C Sleep-inducing preparation
12/02/2008CA2317565C Competitive inhibitors of glyoxalase i and method of generating such competitive inhibitors inside tumor cells
12/02/2008CA2317444C N-acyl cyclic amine derivatives
12/02/2008CA2313878C Composition for suppressing behavior problems of pets
12/02/2008CA2306371C Use of flunarizine for the topical treatment of glaucoma
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2302402C Stereoisomeric indole compounds, process for the preparation of the same, and use thereof
12/02/2008CA2284170C Identification of agents for use in the treatment of alzheimer's disease
12/02/2008CA2278715C Aminooxy-modified oligonucleotides
12/02/2008CA2265672C Pyrazinones and triazinones and their derivatives thereof
12/02/2008CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/02/2008CA2263568C Methods for diagnostic imaging using a contrast agent and a renal vasodilator
12/02/2008CA2257803C Non immunosuppressive antifungal rapalogs
12/02/2008CA2248300C Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
12/02/2008CA2215397C Inhibition of tau-tau-association
12/02/2008CA2205085C An in vitro system for determining formation of a.beta. amyloid
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
12/02/2008CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them
12/02/2008CA2153604C Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields
12/02/2008CA2151219C Thermostable non-reducing saccharide-forming enzyme, its production and uses
12/02/2008CA2140220C Inhibition of infection-stimulated oral tissue destruction by .beta.(1,3)-glucan
12/01/2008CA2632958A1 Patch and patch preparation
11/2008
11/28/2008CA2590605A1 Improvement of mood, memory and cognitive function with pyridoxal 5'-phosphate
1 ... 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 ... 7860